This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Deacetylbisacodyl
DrugBank Accession Number
DB14232
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Thumb
Weight
Average: 277.323
Monoisotopic: 277.110278727
Chemical Formula
C18H15NO2
Synonyms
  • BHPM
  • DDPM
  • Dihydroxydiphenyl-pyridyl methane
External IDs
  • BRN 0212040
  • LA 96
  • LA-96

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcetazolamideThe risk or severity of adverse effects can be increased when Acetazolamide is combined with Deacetylbisacodyl.
AclidiniumThe therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Aclidinium.
AlfentanilThe therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Alfentanil.
AlloinThe risk or severity of adverse effects can be increased when Deacetylbisacodyl is combined with Alloin.
AmantadineThe therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Amantadine.
AmilorideThe risk or severity of adverse effects can be increased when Amiloride is combined with Deacetylbisacodyl.
AmiodaroneThe therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Amiodarone.
AmitriptylineThe therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Amitriptyline.
AmlodipineThe therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Amlodipine.
AmobarbitalThe therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Amobarbital.
Interactions
Identify potential medication risks
Easily compare up to 40 drugs with our drug interaction checker.
Get severity rating, description, and management advice.
Learn more
Food Interactions
Not Available

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
R09078E41Y
CAS number
603-41-8
InChI Key
LJROKJGQSPMTKB-UHFFFAOYSA-N
InChI
InChI=1S/C18H15NO2/c20-15-8-4-13(5-9-15)18(17-3-1-2-12-19-17)14-6-10-16(21)11-7-14/h1-12,18,20-21H
IUPAC Name
4-[(4-hydroxyphenyl)(pyridin-2-yl)methyl]phenol
SMILES
OC1=CC=C(C=C1)C(C1=CC=C(O)C=C1)C1=CC=CC=N1

References

General References
Not Available
ChemSpider
62268
RxNav
1872905
ChEMBL
CHEMBL3544537
ZINC
ZINC000005224913

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0657 mg/mLALOGPS
logP3.36ALOGPS
logP3.79ChemAxon
logS-3.6ALOGPS
pKa (Strongest Acidic)9.57ChemAxon
pKa (Strongest Basic)4.09ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area53.35 Å2ChemAxon
Rotatable Bond Count3ChemAxon
Refractivity81.85 m3·mol-1ChemAxon
Polarizability29.86 Å3ChemAxon
Number of Rings3ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created at July 05, 2018 00:45 / Updated at June 12, 2020 16:53